Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | HPN | P05981 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21730835 | 0.87 | TDP2 (0.46) | TSHRALDH1A1CYP3A4TDP1MEN1 | |
| SCHEMBL10692031 | 0.85 | KMT2A (0.57) | TSHRALDH1A1CYP3A4TDP1MEN1 | |
| SCHEMBL15771707 | 0.85 | CYP1A2 (0.54) | TSHRALDH1A1CYP3A4TDP1MEN1 | |
| SCHEMBL599052 | 0.84 | MAOA (0.46) | TSHRALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL5399227 | 0.78 | TSHR (0.52) | TSHRALDH1A1CYP3A4TDP1MEN1 | |
| SCHEMBL4652610 | 0.77 | MAOA (0.61) | TSHRALDH1A1CYP3A4TDP1MEN1 | |
| SCHEMBL30177232 | 0.77 | MAOA (0.61) | TSHRALDH1A1CYP3A4TDP1MEN1 | |
| SCHEMBL22889028 | 0.77 | METAP1 (0.43) | ALDH1A1MEN1KMT2AMAPTCYP1A2 | |
| SCHEMBL2050323 | 0.77 | GRIA1 (0.31) | HTR5AGRIA1CACNG8 | |
| SCHEMBL21694429 | 0.77 | MAPT (0.45) | ALDH1A1TDP1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112105654-A | Curable resin mixture, curable resin composition, and cured product thereof | 日本化药株式会社 | 2020-12-18 | — | — | CN | disclosed |
| US-10804474-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-10-13 | — | — | US | disclosed |
| US-20200111974-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
| WO-2020031935-A1 | CURABLE RESIN MIXTURE, CURABLE RESIN COMPOSITION, AND CURED PRODUCT | 日本化薬株式会社 | 2020-02-13 | — | — | WO | disclosed |
| US-10550209-B2 | Catalysts for producing polymers and enhanced properties | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-02-04 | — | — | US | disclosed |
| US-20180244816-A1 | Catalysts for Producing Polymers and Enhanced Properties | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-08-30 | — | — | US | disclosed |
| US-9988471-B2 | Catalysts for producing polymers with enhanced properties | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2018-06-05 | — | — | US | disclosed |
| US-20170174798-A1 | Catalysts for Producing Polymers with Enhanced Properties | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-06-22 | — | — | US | disclosed |
| WO-2017105635-A1 | CATALYSTS FOR PRODUCING POLYMERS WITH ENHANCED PROPERTIES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-06-22 | — | — | WO | disclosed |
| EP-0666267-B1 | Organometallic fluorenyl compounds, preparation, and use | PHILLIPS PETROLEUM CO (US) | 2001-04-18 | — | — | EP | disclosed |
| US-6114556-A | Metallocene compound and its use as catalyst component | TARGOR GMBH (DE) | 2000-09-05 | — | — | US | disclosed |
| US-5962359-A | Metallocene compound and its use as catalyst component | TARGOR GMBH (DE) | 1999-10-05 | — | — | US | disclosed |
| US-5571880-A | CATALYSTS FOR POLYMERIZATION OF OLEFINS ESPECIALLY TO OBTAIN SYNDIOTACTIC POLYMERS | PHILLIPS PETROLEUM COMPANY (US) | 1996-11-05 | — | — | US | disclosed |
| EP-0723971-A2 | Metallocenes and their use as catalyst component | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-07-31 | — | — | EP | disclosed |
| EP-0666267-A2 | Organometallic fluorenyl compounds, preparation, and use | PHILLIPS PETROLEUM COMPANY (US) | 1995-08-09 | — | — | EP | disclosed |
| EP-0531443-A4 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | — | 1993-04-21 | — | — | EP | disclosed |
| EP-0531443-A1 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | NOVA PHARMACEUTICAL CORPORATION (US) | 1993-03-17 | — | — | EP | disclosed |
| US-5079260-A | Side effect reduction; fluorene derivatives | NOVA PHARMACEUTICAL CORPORATION (US) | 1992-01-07 | — | — | US | disclosed |
| WO-1991018596-A1 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | WEITZBERG MOSHE (US) | 1991-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10550209-B2 | Catalysts for producing polymers and enhanced properties | PUF60, DBF4, PARN | TSHR 4581/4885ALDH1A1 2010/4885CYP3A4 1045/4885 |
| US-20180244816-A1 | Catalysts for Producing Polymers and Enhanced Properties | PUF60, DBF4, PARN | TSHR 4581/4885ALDH1A1 2010/4885CYP3A4 1045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.